Lung Cancer Surgery Market Synopsis:

Lung Cancer Surgery Market Size was valued at USD 6.04 billion in 2023, and is Projected to Reach USD 8.82 billion by 2032, Growing at a CAGR of 4.3% From 2024-2032.

The lung cancer surgery market is witnessing significant growth driven by advancements in surgical techniques, diagnostic methods, and an increasing prevalence of lung cancer globally. Lung cancer remains one of the leading causes of cancer-related deaths, and surgical resection is one of the most common treatment options for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) when detected at early stages. The growing number of early-stage diagnoses, combined with improved post-surgery outcomes due to advancements in minimally invasive procedures, has expanded the market for lung cancer surgeries.

Technological innovations, such as robotic-assisted surgery and minimally invasive procedures like video-assisted thoracic surgery (VATS) and minimally invasive lobectomy, are revolutionizing the way lung cancer is treated. These techniques offer several advantages, including reduced recovery times, smaller incisions, and less postoperative pain, leading to better patient outcomes and faster return to normal activities. Additionally, with increasing awareness of the benefits of early detection, more patients are undergoing surgery as part of their treatment plan, further boosting market growth.

However, the lung cancer surgery market faces challenges related to the high cost of advanced surgical procedures, especially in emerging markets, and the need for skilled surgeons to perform these complex procedures. Despite these challenges, the market continues to expand, driven by a growing focus on precision medicine, increasing healthcare investments, and the development of novel therapeutic approaches that complement surgical interventions. As the global cancer burden continues to rise, the demand for effective surgical solutions is expected to increase, propelling the lung cancer surgery market forward.

Lung Cancer Surgery Market

Lung Cancer Surgery Market Trend Analysis:

Minimally Invasive Lung Cancer Surgery Techniques Are Gaining Popularity

  • Minimally invasive techniques, such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery, are gaining significant traction in the lung cancer surgery market. These methods offer reduced recovery times, fewer complications, and smaller incisions, which enhance patient outcomes and reduce healthcare costs. The advancement of robotic surgery platforms like the da Vinci Surgical System allows surgeons to perform highly precise and less traumatic surgeries, which is especially beneficial for patients with early-stage lung cancer. The increased adoption of these techniques is expected to drive the market, as more patients opt for less invasive options due to the shorter hospital stays and faster recovery times.

Rise in Personalized and Targeted Lung Cancer Surgeries

  • The shift towards personalized medicine in lung cancer treatment is transforming surgical approaches. With advancements in genetic profiling and molecular diagnostics, surgeons can now better identify specific mutations in tumor cells, enabling them to tailor surgical procedures to individual patients' needs. This trend not only helps in optimizing surgical outcomes but also improves the overall prognosis by targeting specific cancerous cells during the surgery. Personalized surgery combined with adjunct therapies, like targeted therapies and immunotherapies, are expected to become the standard of care, enhancing the demand for more precise and individualized surgical interventions in lung cancer.

Lung Cancer Surgery Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America is expected to dominate the lung cancer surgery market over the forecast period, driven by the region's advanced healthcare infrastructure, high healthcare expenditure, and increasing adoption of cutting-edge surgical technologies. The presence of major healthcare players, along with robust research and development activities focused on improving surgical techniques and patient outcomes, further strengthens the market position. Additionally, the rising prevalence of lung cancer, particularly among the aging population, and the growing demand for minimally invasive surgical procedures contribute to North America's leading role in the global market. The availability of specialized treatment centers and the high rate of adoption of personalized medicine also support the region's dominance in this market.

Active Key Players in the Lung Cancer Surgery Market:

  • AngioDynamics (United States),

  • Ackermann (Germany),
  • Scanlan International (United States),
  • KLS Martin Group (Germany),
  • Wexler Surgical (United States),
  • Lepu Medical Technology (Beijing) Co., Ltd. (China),
  • Intuitive Surgical (United States),
  • FusionKraft (Germany),
  • Surgical Holdings (United Kingdom),
  • GerMedUSA (United States),
  • Medtronic (Ireland),
  • Accuray Incorporated (United States),
  • Teleflex Incorporated (United States),
  • KARL STORZ SE & Co. KG (Germany),
  • TROKAMED GmbH (Germany),
  • Richard Wolf GmbH (Germany),
  • Sontec Instruments, Inc. (United States),
  • asap endoscopic products GmbH (Germany),
  • FUJIFILM Holdings America Corporation (United States),
  • Ambu A/S (Denmark),
  • Johnson & Johnson Services, Inc (United States),
  • Olympus Corporation (Japan),
  • Other Active Players

Lung Cancer Surgery Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 6.04 Billion

Forecast Period 2024-32 CAGR:

 6.3%

Market Size in 2032:

USD 8.82 Billion

Segments Covered:

By Product Type
  • Surgical Instruments
  • Monitoring & Visualizing System
  •  Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems
  • Others

By Surgery Type
  • Open Surgery,
  • Minimally Invasive Surgery

By Procedure
  • Lobectomy
  • Segmentectomy/Wedge Resection
  •  Pneumonectomy
  • Sleeve Resection
  • Extended Resection

By Cancer Stage
  • Early-Stage,
  • Advanced-Stage

By End user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Lung cancer surgery is growing due to rising prevalence and improved surgical techniques.

Key Market Restraints:
  • High treatment costs and the complexity of lung cancer surgeries may hinder market growth.

Key Opportunities:
  • Rising demand for minimally invasive operations and individualized treatment choices offer market growth prospects.

Companies Covered in the report:
  • AngioDynamics (United States), Ackermann (Germany), Scanlan International (United States), KLS Martin Group (Germany), Wexler Surgical (United States), Lepu Medical Technology (Beijing) Co., Ltd. (China), Intuitive Surgical (United States), FusionKraft (Germany), Surgical Holdings (United Kingdom), GerMedUSA (United States), Medtronic (Ireland), Accuray Incorporated (United States), Teleflex Incorporated (United States), KARL STORZ SE & Co. KG (Germany), TROKAMED GmbH (Germany), Richard Wolf GmbH (Germany), Sontec Instruments, Inc. (United States), asap endoscopic products GmbH (Germany), FUJIFILM Holdings America Corporation (United States), Ambu A/S (Denmark), Johnson & Johnson Services, Inc (United States), Olympus Corporation (Japan), and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Lung Cancer Surgery Market by Product Type
 4.1 Lung Cancer Surgery Market Snapshot and Growth Engine
 4.2 Lung Cancer Surgery Market Overview
 4.3 Surgical Instruments
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Surgical Instruments: Geographic Segmentation Analysis
 4.4 Monitoring & Visualizing System
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Monitoring & Visualizing System: Geographic Segmentation Analysis
 4.5 Endosurgical Equipment
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Endosurgical Equipment: Geographic Segmentation Analysis
 4.6 Robotic-Assisted Thoracic Surgery Systems and Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Robotic-Assisted Thoracic Surgery Systems and Others: Geographic Segmentation Analysis

Chapter 5: Lung Cancer Surgery Market by Surgery Type
 5.1 Lung Cancer Surgery Market Snapshot and Growth Engine
 5.2 Lung Cancer Surgery Market Overview
 5.3 Open Surgery
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Open Surgery: Geographic Segmentation Analysis
 5.4 Minimally Invasive Surgery
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Minimally Invasive Surgery: Geographic Segmentation Analysis

Chapter 6: Lung Cancer Surgery Market by Procedure
 6.1 Lung Cancer Surgery Market Snapshot and Growth Engine
 6.2 Lung Cancer Surgery Market Overview
 6.3 Lobectomy
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Lobectomy: Geographic Segmentation Analysis
 6.4 Segmentectomy/Wedge Resection
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Segmentectomy/Wedge Resection: Geographic Segmentation Analysis
 6.5 Pneumonectomy
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Pneumonectomy: Geographic Segmentation Analysis
 6.6 Sleeve Resection
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Sleeve Resection: Geographic Segmentation Analysis
 6.7 Extended Resection
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Extended Resection: Geographic Segmentation Analysis

Chapter 7: Lung Cancer Surgery Market by Cancer Stage
 7.1 Lung Cancer Surgery Market Snapshot and Growth Engine
 7.2 Lung Cancer Surgery Market Overview
 7.3 Early-Stage
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Early-Stage: Geographic Segmentation Analysis
 7.4 Advanced-Stage
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Advanced-Stage: Geographic Segmentation Analysis

Chapter 8: Lung Cancer Surgery Market by End user
 8.1 Lung Cancer Surgery Market Snapshot and Growth Engine
 8.2 Lung Cancer Surgery Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Geographic Segmentation Analysis
 8.4 Ambulatory Surgical Centers
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
 8.5 Specialty Clinics
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Specialty Clinics: Geographic Segmentation Analysis

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Benchmarking
  9.1.2 Lung Cancer Surgery Market Share by Manufacturer (2023)
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Mergers and Acquisitions  
 9.2 ANGIODYNAMICS (UNITED STATES)
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Role of the Company in the Market
  9.2.5 Sustainability and Social Responsibility
  9.2.6 Operating Business Segments
  9.2.7 Product Portfolio
  9.2.8 Business Performance
  9.2.9 Key Strategic Moves and Recent Developments
  9.2.10 SWOT Analysis
 9.3 ACKERMANN (GERMANY)
 9.4 SCANLAN INTERNATIONAL (UNITED STATES)
 9.5 KLS MARTIN GROUP (GERMANY)
 9.6 WEXLER SURGICAL (UNITED STATES)
 9.7 LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD. (CHINA)
 9.8 INTUITIVE SURGICAL (UNITED STATES)
 9.9 FUSIONKRAFT (GERMANY)
 9.10 SURGICAL HOLDINGS (UNITED KINGDOM)
 9.11 GERMEDUSA (UNITED STATES)
 9.12 MEDTRONIC (IRELAND)
 9.13 ACCURAY INCORPORATED (UNITED STATES)
 9.14 TELEFLEX INCORPORATED (UNITED STATES)
 9.15 KARL STORZ SE & CO. KG (GERMANY)
 9.16 TROKAMED GMBH (GERMANY)
 9.17 RICHARD WOLF GMBH (GERMANY)
 9.18 SONTEC INSTRUMENTS INC. (UNITED STATES)
 9.19 ASAP ENDOSCOPIC PRODUCTS GMBH (GERMANY)
 9.20 FUJIFILM HOLDINGS AMERICA CORPORATION (UNITED STATES)
 9.21 AMBU A/S (DENMARK)
 9.22 JOHNSON & JOHNSON SERVICES INC (UNITED STATES)
 9.23 OLYMPUS CORPORATION (JAPAN)
 9.24 AMONG OTHER ACTIVE PLAYERS

Chapter 10: Global Lung Cancer Surgery Market By Region
 10.1 Overview
 10.2. North America Lung Cancer Surgery Market
  10.2.1 Key Market Trends, Growth Factors and Opportunities
  10.2.2 Top Key Companies
  10.2.3 Historic and Forecasted Market Size by Segments
  10.2.4 Historic and Forecasted Market Size By Product Type
  10.2.4.1 Surgical Instruments
  10.2.4.2 Monitoring & Visualizing System
  10.2.4.3 Endosurgical Equipment
  10.2.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.2.5 Historic and Forecasted Market Size By Surgery Type
  10.2.5.1 Open Surgery
  10.2.5.2 Minimally Invasive Surgery
  10.2.6 Historic and Forecasted Market Size By Procedure
  10.2.6.1 Lobectomy
  10.2.6.2 Segmentectomy/Wedge Resection
  10.2.6.3 Pneumonectomy
  10.2.6.4 Sleeve Resection
  10.2.6.5 Extended Resection
  10.2.7 Historic and Forecasted Market Size By Cancer Stage
  10.2.7.1 Early-Stage
  10.2.7.2 Advanced-Stage
  10.2.8 Historic and Forecasted Market Size By End user
  10.2.8.1 Hospitals
  10.2.8.2 Ambulatory Surgical Centers
  10.2.8.3 Specialty Clinics
  10.2.9 Historic and Forecast Market Size by Country
  10.2.9.1 US
  10.2.9.2 Canada
  10.2.9.3 Mexico
 10.3. Eastern Europe Lung Cancer Surgery Market
  10.3.1 Key Market Trends, Growth Factors and Opportunities
  10.3.2 Top Key Companies
  10.3.3 Historic and Forecasted Market Size by Segments
  10.3.4 Historic and Forecasted Market Size By Product Type
  10.3.4.1 Surgical Instruments
  10.3.4.2 Monitoring & Visualizing System
  10.3.4.3 Endosurgical Equipment
  10.3.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.3.5 Historic and Forecasted Market Size By Surgery Type
  10.3.5.1 Open Surgery
  10.3.5.2 Minimally Invasive Surgery
  10.3.6 Historic and Forecasted Market Size By Procedure
  10.3.6.1 Lobectomy
  10.3.6.2 Segmentectomy/Wedge Resection
  10.3.6.3 Pneumonectomy
  10.3.6.4 Sleeve Resection
  10.3.6.5 Extended Resection
  10.3.7 Historic and Forecasted Market Size By Cancer Stage
  10.3.7.1 Early-Stage
  10.3.7.2 Advanced-Stage
  10.3.8 Historic and Forecasted Market Size By End user
  10.3.8.1 Hospitals
  10.3.8.2 Ambulatory Surgical Centers
  10.3.8.3 Specialty Clinics
  10.3.9 Historic and Forecast Market Size by Country
  10.3.9.1 Russia
  10.3.9.2 Bulgaria
  10.3.9.3 The Czech Republic
  10.3.9.4 Hungary
  10.3.9.5 Poland
  10.3.9.6 Romania
  10.3.9.7 Rest of Eastern Europe
 10.4. Western Europe Lung Cancer Surgery Market
  10.4.1 Key Market Trends, Growth Factors and Opportunities
  10.4.2 Top Key Companies
  10.4.3 Historic and Forecasted Market Size by Segments
  10.4.4 Historic and Forecasted Market Size By Product Type
  10.4.4.1 Surgical Instruments
  10.4.4.2 Monitoring & Visualizing System
  10.4.4.3 Endosurgical Equipment
  10.4.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.4.5 Historic and Forecasted Market Size By Surgery Type
  10.4.5.1 Open Surgery
  10.4.5.2 Minimally Invasive Surgery
  10.4.6 Historic and Forecasted Market Size By Procedure
  10.4.6.1 Lobectomy
  10.4.6.2 Segmentectomy/Wedge Resection
  10.4.6.3 Pneumonectomy
  10.4.6.4 Sleeve Resection
  10.4.6.5 Extended Resection
  10.4.7 Historic and Forecasted Market Size By Cancer Stage
  10.4.7.1 Early-Stage
  10.4.7.2 Advanced-Stage
  10.4.8 Historic and Forecasted Market Size By End user
  10.4.8.1 Hospitals
  10.4.8.2 Ambulatory Surgical Centers
  10.4.8.3 Specialty Clinics
  10.4.9 Historic and Forecast Market Size by Country
  10.4.9.1 Germany
  10.4.9.2 UK
  10.4.9.3 France
  10.4.9.4 The Netherlands
  10.4.9.5 Italy
  10.4.9.6 Spain
  10.4.9.7 Rest of Western Europe
 10.5. Asia Pacific Lung Cancer Surgery Market
  10.5.1 Key Market Trends, Growth Factors and Opportunities
  10.5.2 Top Key Companies
  10.5.3 Historic and Forecasted Market Size by Segments
  10.5.4 Historic and Forecasted Market Size By Product Type
  10.5.4.1 Surgical Instruments
  10.5.4.2 Monitoring & Visualizing System
  10.5.4.3 Endosurgical Equipment
  10.5.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.5.5 Historic and Forecasted Market Size By Surgery Type
  10.5.5.1 Open Surgery
  10.5.5.2 Minimally Invasive Surgery
  10.5.6 Historic and Forecasted Market Size By Procedure
  10.5.6.1 Lobectomy
  10.5.6.2 Segmentectomy/Wedge Resection
  10.5.6.3 Pneumonectomy
  10.5.6.4 Sleeve Resection
  10.5.6.5 Extended Resection
  10.5.7 Historic and Forecasted Market Size By Cancer Stage
  10.5.7.1 Early-Stage
  10.5.7.2 Advanced-Stage
  10.5.8 Historic and Forecasted Market Size By End user
  10.5.8.1 Hospitals
  10.5.8.2 Ambulatory Surgical Centers
  10.5.8.3 Specialty Clinics
  10.5.9 Historic and Forecast Market Size by Country
  10.5.9.1 China
  10.5.9.2 India
  10.5.9.3 Japan
  10.5.9.4 South Korea
  10.5.9.5 Malaysia
  10.5.9.6 Thailand
  10.5.9.7 Vietnam
  10.5.9.8 The Philippines
  10.5.9.9 Australia
  10.5.9.10 New Zealand
  10.5.9.11 Rest of APAC
 10.6. Middle East & Africa Lung Cancer Surgery Market
  10.6.1 Key Market Trends, Growth Factors and Opportunities
  10.6.2 Top Key Companies
  10.6.3 Historic and Forecasted Market Size by Segments
  10.6.4 Historic and Forecasted Market Size By Product Type
  10.6.4.1 Surgical Instruments
  10.6.4.2 Monitoring & Visualizing System
  10.6.4.3 Endosurgical Equipment
  10.6.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.6.5 Historic and Forecasted Market Size By Surgery Type
  10.6.5.1 Open Surgery
  10.6.5.2 Minimally Invasive Surgery
  10.6.6 Historic and Forecasted Market Size By Procedure
  10.6.6.1 Lobectomy
  10.6.6.2 Segmentectomy/Wedge Resection
  10.6.6.3 Pneumonectomy
  10.6.6.4 Sleeve Resection
  10.6.6.5 Extended Resection
  10.6.7 Historic and Forecasted Market Size By Cancer Stage
  10.6.7.1 Early-Stage
  10.6.7.2 Advanced-Stage
  10.6.8 Historic and Forecasted Market Size By End user
  10.6.8.1 Hospitals
  10.6.8.2 Ambulatory Surgical Centers
  10.6.8.3 Specialty Clinics
  10.6.9 Historic and Forecast Market Size by Country
  10.6.9.1 Turkiye
  10.6.9.2 Bahrain
  10.6.9.3 Kuwait
  10.6.9.4 Saudi Arabia
  10.6.9.5 Qatar
  10.6.9.6 UAE
  10.6.9.7 Israel
  10.6.9.8 South Africa
 10.7. South America Lung Cancer Surgery Market
  10.7.1 Key Market Trends, Growth Factors and Opportunities
  10.7.2 Top Key Companies
  10.7.3 Historic and Forecasted Market Size by Segments
  10.7.4 Historic and Forecasted Market Size By Product Type
  10.7.4.1 Surgical Instruments
  10.7.4.2 Monitoring & Visualizing System
  10.7.4.3 Endosurgical Equipment
  10.7.4.4 Robotic-Assisted Thoracic Surgery Systems and Others
  10.7.5 Historic and Forecasted Market Size By Surgery Type
  10.7.5.1 Open Surgery
  10.7.5.2 Minimally Invasive Surgery
  10.7.6 Historic and Forecasted Market Size By Procedure
  10.7.6.1 Lobectomy
  10.7.6.2 Segmentectomy/Wedge Resection
  10.7.6.3 Pneumonectomy
  10.7.6.4 Sleeve Resection
  10.7.6.5 Extended Resection
  10.7.7 Historic and Forecasted Market Size By Cancer Stage
  10.7.7.1 Early-Stage
  10.7.7.2 Advanced-Stage
  10.7.8 Historic and Forecasted Market Size By End user
  10.7.8.1 Hospitals
  10.7.8.2 Ambulatory Surgical Centers
  10.7.8.3 Specialty Clinics
  10.7.9 Historic and Forecast Market Size by Country
  10.7.9.1 Brazil
  10.7.9.2 Argentina
  10.7.9.3 Rest of SA

Chapter 11 Analyst Viewpoint and Conclusion
11.1 Recommendations and Concluding Analysis
11.2 Potential Market Strategies

Chapter 12 Research Methodology
12.1 Research Process
12.2 Primary Research
12.3 Secondary Research
 

Lung Cancer Surgery Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 6.04 Billion

Forecast Period 2024-32 CAGR:

 6.3%

Market Size in 2032:

USD 8.82 Billion

Segments Covered:

By Product Type
  • Surgical Instruments
  • Monitoring & Visualizing System
  •  Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems
  • Others

By Surgery Type
  • Open Surgery,
  • Minimally Invasive Surgery

By Procedure
  • Lobectomy
  • Segmentectomy/Wedge Resection
  •  Pneumonectomy
  • Sleeve Resection
  • Extended Resection

By Cancer Stage
  • Early-Stage,
  • Advanced-Stage

By End user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Lung cancer surgery is growing due to rising prevalence and improved surgical techniques.

Key Market Restraints:
  • High treatment costs and the complexity of lung cancer surgeries may hinder market growth.

Key Opportunities:
  • Rising demand for minimally invasive operations and individualized treatment choices offer market growth prospects.

Companies Covered in the report:
  • AngioDynamics (United States), Ackermann (Germany), Scanlan International (United States), KLS Martin Group (Germany), Wexler Surgical (United States), Lepu Medical Technology (Beijing) Co., Ltd. (China), Intuitive Surgical (United States), FusionKraft (Germany), Surgical Holdings (United Kingdom), GerMedUSA (United States), Medtronic (Ireland), Accuray Incorporated (United States), Teleflex Incorporated (United States), KARL STORZ SE & Co. KG (Germany), TROKAMED GmbH (Germany), Richard Wolf GmbH (Germany), Sontec Instruments, Inc. (United States), asap endoscopic products GmbH (Germany), FUJIFILM Holdings America Corporation (United States), Ambu A/S (Denmark), Johnson & Johnson Services, Inc (United States), Olympus Corporation (Japan), and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Lung Cancer Surgery Market research report?
The forecast period in the Lung Cancer Surgery Market research report is 2024-2032.
Who are the key players in the Lung Cancer Surgery Market?
AngioDynamics (United States), Ackermann (Germany), Scanlan International (United States), KLS Martin Group (Germany), Wexler Surgical (United States), Lepu Medical Technology (Beijing) Co., Ltd. (China), Intuitive Surgical (United States), FusionKraft (Germany), Surgical Holdings (United Kingdom), GerMedUSA (United States), Medtronic (Ireland), Accuray Incorporated (United States), Teleflex Incorporated (United States), KARL STORZ SE & Co. KG (Germany), TROKAMED GmbH (Germany), Richard Wolf GmbH (Germany), Sontec Instruments, Inc. (United States), asap endoscopic products GmbH (Germany), FUJIFILM Holdings America Corporation (United States), Ambu A/S (Denmark), Johnson & Johnson Services, Inc (United States), Olympus Corporation (Japan), and Other Active Players.
What are the segments of the Lung Cancer Surgery Market?
The Lung Cancer Surgery Market is segmented into By Product Type, By Surgery Type, By Procedure , By Cancer Stage and region. By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems and Others), By Surgery Type (Open Surgery, Minimally Invasive Surgery), By Procedure (Lobectomy, Segmentectomy/Wedge Resection, Pneumonectomy, Sleeve Resection, Extended Resection), By Cancer Stage (Early-Stage, Advanced-Stage), By End user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA)
What is the Lung Cancer Surgery Market?
Lung cancer surgery refers to medical procedures used to remove tumors or cancerous tissue from the lungs to treat lung cancer. It is typically considered for patients with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) when the tumor is localized and resectable. The primary types of lung cancer surgery include lobectomy (removal of a lung lobe), pneumonectomy (removal of an entire lung), and segmentectomy (removal of a part of a lobe). Surgical options depend on the stage of cancer, the patient's overall health, and the tumor's location. The goal of surgery is to eliminate cancerous tissue, reduce the risk of metastasis, and improve survival rates.
How big is the Lung Cancer Surgery Market?
Lung Cancer Surgery Market Size was valued at USD 6.04 billion in 2023, and is Projected to Reach USD 8.82 billion by 2032, Growing at a CAGR of 4.3% From 2024-2032.